The novel tumour suppressor Madm regulates stem cell competition in the Drosophila testis

Shree Ram Singh1, Ying Liu1, Jiangsha Zhao1

  • 1The Basic Research Laboratory, National Cancer Institute, National Institutes of Health, Frederick, Maryland 21702, USA.

Nature Communications
|January 22, 2016
PubMed

Insights

A novel tumor suppressor, Madm, regulates stem cell competition. Madm knockdown in somatic cyst stem cells (CySCs) drives overproliferation, enabling them to outcompete germline stem cells (GSCs) and initiate tumors.

Area of Science:

  • Developmental Biology
  • Cancer Biology
  • Stem Cell Biology

Background:

  • Stem cell competition is a key mechanism for maintaining tissue homeostasis and preventing tumor formation.
  • The molecular underpinnings of stem cell competition and its role in tumorigenesis remain largely unexplored.

Purpose of the Study:

  • To identify novel molecular regulators of stem cell competition.
  • To elucidate the mechanism by which stem cell competition controls tumor initiation.

Main Methods:

  • Utilized Drosophila melanogaster as a model organism.
  • Investigated the role of Mlf1-adaptor molecule (Madm) in regulating germline stem cell (GSC) and somatic cyst stem cell (CySC) interactions.
  • Analyzed gene expression and signaling pathways, including EGF receptor and JAK/STAT pathways.

Main Results:

  • Identified Madm as a novel tumor suppressor regulating stem cell competition.
  • Madm knockdown leads to overexpression of the EGF receptor ligand vein (vn), promoting CySC overproliferation and competitive advantage.
  • Constitutively active JAK kinase (hopTum-l) promotes Madm nuclear translocation, suppressing CySC proliferation and favoring GSC competition, leading to GSC tumor formation.

Conclusions:

  • Madm-mediated regulation of stem cell competition is a critical mechanism for controlling stem cell behavior and preventing tumor initiation.
  • Dysregulation of this pathway can lead to stem cell overproliferation and tumor formation.
  • This study provides insights into potential therapeutic strategies targeting stem cell competition in cancer treatment.